The Veratrak Advisory Board is made up of individuals with deep expertise and experience across Pharmaceuticals, Supply Chain, Manufacturing, Packaging, Digital, and Technology. They advise and guide Veratrak as we improve collaboration across the pharmaceutical supply chain.
Charles is a consummate insider in the tech scene and a leading technology investor. He previously worked at Microsoft as head of Global strategy, reporting directly to the CEO. Charlie directed the acquisition of both Yahoo and Skype and, alongside Bill Gates, negotiated Microsoft’s entry into Facebook. Charles now manages his own VC which has large stakes in the quantum computing, biotech, space and enterprise SaaS industries.
Dr. Heinrich Zetlmayer
Heinrich Zetlmayer, General Partner at Blockchain Valley Ventures, is an accomplished digital investor and board member. With more than 20 years experience in Supply Chain Management and Operations, Heinrich was a VP at IBM's Global Business Services leading Supply Chain and Operations Management Services in EMEA.
Tony brings over 30 years of strategic, supply chain, and operations experience in the logistics, pharmaceutical and medical device industries. Currently, Tony is EVP Operations at Vectura Group, and previously worked at Baxter for 18 years including serving as VP Global Supply Chain, and VP Operations EMEA.
Antonin de Fougerolles
Antonin de Fougerolles is the CEO of Evox Therapeutics and a Venture Partner at Ascension Ventures with over 20 years’ experience in the pharmaceutical and biotechnology industry. He has a background in developing transformative therapeutic drug platforms in the nucleic acid and biologics space. His expertise has led to the progression of multiple assets through clinical trials. Prior to joining Evox Therapeutics, Tony was CSO at Ablynx NV and Moderna Therapeutics, and VP Research at Alnylam Pharmaceuticals. He holds a PhD in Immunology from Harvard University.
Agash Navaranjan is an experienced technologist in the Blockchain space. Currently the CTO of DoveTail Lab working on creating audit trails for medical data transfer. Previously Agash ran a Blockchain consultancy working with clients such as HSBC, Rabo Bank and various startups working with using Ethereum and Hyperledger Fabric.
Dexter is an experienced senior executive in the pharmaceutical industry. Currently, he is Director Corporate Strategy at Tjoapack, a leading pharmaceutical contract services organisation, reporting directly to the CEO. He is responsible for business strategy and growth of the company. Dexter brings supply chain, commercial, and technology expertise with a track record of leading large innovation and change projects. He holds an MSc in mathematics and computer science from the University of Oxford and has previously worked in technology sector.
David is a highly driven and energetic leader, with over 30 years of experience in the deployment of innovative and sustainable solutions for the pharmaceutical sector. David has previously worked as Head of End to End Supply Chain Design at Merck, and as a Global Strategy and Innovation Director of GSK. David brings an extensive track record of leading major initiatives, including systems deployment projects, restructuring organisational functions, strategy development and deployment.